MGMT and cancer: Previously, we synthetized compounds, relying on conjugating of the MGMT inhibitors O6BG and O6BTG with a C8-linker to ß-D-glucose (the conjugates are O6BG-Glu and O6BTG-Glu respectively), in order to achieve an active targeting of cancer cells27.